CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy

Autor: Meshitsuka, Sohsuke, Ninomiya, Ryo, Nagamura-Inoue, Tokiko, Okada, Takashi, Futami, Muneyoshi, Tojo, Arinobu
Zdroj: In Regenerative Therapy December 2022 21:442-452
Databáze: ScienceDirect